REDWOOD CITY, Calif. — GenapSys Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced the appointment of Fredrik Eliasson, Diana McKenzie, and Loretta Cecil to its Board of Directors. “I am delighted to welcome our new Board members during this exciting phase of transformation and growth for GenapSys,” said Jason Myers, Ph.D., Chief Executive Officer […]
— New Storage Technologies Needed to Address Emerging Data Oceans — — Dense, Stable, Low Power Data Storage in DNA Provides Option to Traditional Storage — SOUTH SAN FRANCISCO, Calif. — The DNA Data Storage Alliance, an organization of more than 25 leading companies formed by Twist Bioscience Corporation (NASDAQ: TWST), Illumina, Inc. (NASDAQ: ILMN) and Western Digital (NASDAQ: WDC) […]
MINNEAPOLIS and LONDON — Bio-Techne Corporation (NASDAQ: TECH), a leader in developing innovative tools and technologies for cell and gene therapy research and manufacturing, has partnered with Autolomous to implement a first of its kind electronic batch record system, AutoloMATETM, at Bio-Techne’s GMP cellular manufacturing center. Through this partnership Bio-Techne will be able to offer […]
The Rockefeller Foundation has announced over $20 million in funding to help strengthen global capabilities to detect and respond to pandemic threats by strengthening organisations’ ability to sequence and share genomic information alongside other data, rapidly. Oxford Nanopore is one of 20 organisations collaborating with the Rockefeller Foundation to shape their new Pandemic Prevention Institute and expand […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its synthetic RNA reference controls for the SARS-CoV-2 Kappa (B.1.617.1) variant strain. The company is also working on controls for the […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it is joining the Cell and Gene Therapy Catapult process analytical technology (PAT) consortium, which includes over 20 pharmaceutical companies, technology providers, therapy developers, and charities. The consortium will assess the application and combination of multiple technologies for process analytics within the cell and gene therapy industry. […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today welcomed Neil Ward to the new role of Vice President and General Manager for the company’s Europe, Middle East, and Africa (EMEA) region to expand and develop the team and infrastructure to capitalize on the […]
Company offers preview of extraction protocol selected as a finalist for XPRIZE Rapid COVID Testing Competition Pleasanton, Calif. – Purigen Biosystems, Inc., a leading provider of next-generation technologies for extracting and purifying nucleic acids from biological samples, today announced the launch of an early access program for its Ionic® Pure Viral RNA Kit. The new […]
Promega GoTaq® Rapid Master Mix paired with Eppendorf Mastercycler® X50s thermal cycler is one of the fastest endpoint PCR Madison, WI USA. Biotech and pharma labs performing endpoint polymerase chain reaction (PCR) can amplify samples in as little as 15 minutes with new Promega GoTaq® Rapid Master Mix paired with the Eppendorf Mastercycler® X50s thermal cycler. The combination […]
Panel enables early identification of new and known variants from a variety of sample types CARLSBAD, Calif. — Thermo Fisher Scientific today introduced the Ion AmpliSeq SARS-CoV-2 Insight Research Assay to improve SARS-CoV-2 surveillance. The assay is designed to enable early identification of new and known variants from samples that have lower viral loads. By sequencing more than 99 […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
